AstraZeneca Partners With Alivecor For Kidney Care Breakthrough

AliveCor’s Kardia-K AI measuring device has attracted AstraZeneca’s attention for its ability to innovatively measure a patient’s potassium level. The leading pharmaceuticals company and the developer of personal ECG devices based on artificial intelligence are joining forces in an effort to find new solutions to cardio, renal and metabolic issues. The project will focus on […]